INVO Fertility, Inc.

IVF
$0.94 (- $0.00 - 0.34%)
Last updated: 2026-08-01 07:06 UTC
IVF Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryMedical Devices
ISINUS44984F3029
CUSIP44984F302
Market Price0.94
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-294.88
Market Cap$13.2M
Book Value-4.47
Price to Book-0.196
BetaN/A
52w High299.52
52w Low0.86
Next Earnings DateN/A

INVO Fertility, Inc. trades under ticker IVF on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US44984F3029, CUSIP 44984F302. Also searched as INVO Fertility.

Related researchIVF stock priceIVF share priceINVO Fertility stockINVO Fertility share price44984F302
About the Company
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Price History